1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
1.8. Key Benefits to the Stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Processes
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. Analyst View
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. CORNEAL IMPLANTS MARKET BY TYPE OF CORNEAL IMPLANTS
5.1. Introduction
5.2. Penetrating Keratoplasty (PKP)
5.2.1. Market Trends and Opportunities
5.2.2. Growth Prospects
5.3. Deep Anterior Lamellar Keratoplasty (DALK)
5.3.1. Market Trends and Opportunities
5.3.2. Growth Prospects
5.4. Descemet’s Stripping Automated Endothelial Keratoplasty (DSAEK)
5.4.1. Market Trends and Opportunities
5.4.2. Growth Prospects
5.5. Descemet Membrane Endothelial Keratoplasty (DMEK)
5.5.1. Market Trends and Opportunities
5.5.2. Growth Prospects
6. CORNEAL IMPLANTS MARKET BY SOURCE OF CORNEAL TISSUE
6.1. Introduction
6.2. Allografts
6.2.1. Market Trends and Opportunities
6.2.2. Growth Prospects
6.3. Synthetic Corneal Implants
6.3.1. Market Trends and Opportunities
6.3.2. Growth Prospects
7. CORNEAL IMPLANTS MARKET BY INDICATIONS
7.1. Introduction
7.2. Corneal Scarring
7.2.1. Market Trends and Opportunities
7.2.2. Growth Prospects
7.3. Fuchs’ Endothelial Dystrophy
7.3.1. Market Trends and Opportunities
7.3.2. Growth Prospects
7.4. Bullous Keratopathy
7.4.1. Market Trends and Opportunities
7.4.2. Growth Prospects
7.5. Other Corneal Diseases
7.5.1. Market Trends and Opportunities
7.5.2. Growth Prospects
8. CORNEAL IMPLANTS MARKET BY END-USER
8.1. Introduction
8.2. Hospitals
8.2.1. Market Trends and Opportunities
8.2.2. Growth Prospects
8.3. Eye Banks
8.3.1. Market Trends and Opportunities
8.3.2. Growth Prospects
8.4. Ambulatory Surgery Centers (ASCs)
8.4.1. Market Trends and Opportunities
8.4.2. Growth Prospects
9. CORNEAL IMPLANTS MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. By Type of Corneal Implants
9.2.2. By Source of Corneal Tissue
9.2.3. By Indications
9.2.4. By End User
9.2.5. By Country
9.2.5.1. United States
9.2.5.1.1. Market Trends and Opportunities
9.2.5.1.2. Growth Prospects
9.2.5.2. Canada
9.2.5.2.1. Market Trends and Opportunities
9.2.5.2.2. Growth Prospects
9.2.5.3. Mexico
9.2.5.3.1. Market Trends and Opportunities
9.2.5.3.2. Growth Prospects
9.3. South America
9.3.1. By Type of Corneal Implants
9.3.2. By Source of Corneal Tissue
9.3.3. By Indications
9.3.4. By End User
9.3.5. By Country
9.3.5.1. Brazil
9.3.5.1.1. Market Trends and Opportunities
9.3.5.1.2. Growth Prospects
9.3.5.2. Argentina
9.3.5.2.1. Market Trends and Opportunities
9.3.5.2.2. Growth Prospects
9.3.5.3. Others
9.3.5.3.1. Market Trends and Opportunities
9.3.5.3.2. Growth Prospects
9.4. Europe
9.4.1. By Type of Corneal Implants
9.4.2. By Source of Corneal Tissue
9.4.3. By Indications
9.4.4. By End User
9.4.5. By Country
9.4.5.1. United Kingdom
9.4.5.1.1. Market Trends and Opportunities
9.4.5.1.2. Growth Prospects
9.4.5.2. Germany
9.4.5.2.1. Market Trends and Opportunities
9.4.5.2.2. Growth Prospects
9.4.5.3. France
9.4.5.3.1. Market Trends and Opportunities
9.4.5.3.2. Growth Prospects
9.4.5.4. Italy
9.4.5.4.1. Market Trends and Opportunities
9.4.5.4.2. Growth Prospects
9.4.5.5. Spain
9.4.5.5.1. Market Trends and Opportunities
9.4.5.5.2. Growth Prospects
9.4.5.6. Others
9.4.5.6.1. Market Trends and Opportunities
9.4.5.6.2. Growth Prospects
9.5. Middle East and Africa
9.5.1. By Type of Corneal Implants
9.5.2. By Source of Corneal Tissue
9.5.3. By Indications
9.5.4. By End User
9.5.5. By Country
9.5.5.1. Saudi Arabia
9.5.5.1.1. Market Trends and Opportunities
9.5.5.1.2. Growth Prospects
9.5.5.2. UAE
9.5.5.2.1. Market Trends and Opportunities
9.5.5.2.2. Growth Prospects
9.5.5.3. Others
9.5.5.3.1. Market Trends and Opportunities
9.5.5.3.2. Growth Prospects
9.6. Asia Pacific
9.6.1. By Type of Corneal Implants
9.6.2. By Source of Corneal Tissue
9.6.3. By Indications
9.6.4. By End User
9.6.5. By Country
9.6.5.1. Japan
9.6.5.1.1. Market Trends and Opportunities
9.6.5.1.2. Growth Prospects
9.6.5.2. China
9.6.5.2.1. Market Trends and Opportunities
9.6.5.2.2. Growth Prospects
9.6.5.3. India
9.6.5.3.1. Market Trends and Opportunities
9.6.5.3.2. Growth Prospects
9.6.5.4. South Korea
9.6.5.4.1. Market Trends and Opportunities
9.6.5.4.2. Growth Prospects
9.6.5.5. Taiwan
9.6.5.5.1. Market Trends and Opportunities
9.6.5.5.2. Growth Prospects
9.6.5.6. Thailand
9.6.5.6.1. Market Trends and Opportunities
9.6.5.6.2. Growth Prospects
9.6.5.7. Indonesia
9.6.5.7.1. Market Trends and Opportunities
9.6.5.7.2. Growth Prospects
9.6.5.8. Others
9.6.5.8.1. Market Trends and Opportunities
9.6.5.8.2. Growth Prospects
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Mediphacos
11.2. Aurolab
11.3. CorneaGen
11.4. DIOPTEX
11.5. AJL Opthalmic SA
11.6. EyeYon Medical
11.7. CorNeat Vision
11.8. LinkoCare Life Sciences AB
11.9. Massachusetts Eye and Ear
11.10. San Diego Eye Bank
11.11. KeraMed, Inc.